Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker TMCI
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 24, 2026 | John T. Treace Chief Executive Officer, Director, 10%… | TMCI Treace Medical Concepts, Inc. | Buy | 11,000 | $4.34 | $47.7K Buy | Form 4 ↗ |
| Aug 21, 2026 | John T. Treace Chief Executive Officer, Director, 10%… | TMCI Treace Medical Concepts, Inc. | Buy | 5,000 | $4.35 | $21.8K Buy | Form 4 ↗ |
| Aug 20, 2026 | John T. Treace Chief Executive Officer, Director, 10%… | TMCI Treace Medical Concepts, Inc. | Buy | 39,944 | $4.44 | $177.4K Buy | Form 4 ↗ |
| Jun 11, 2026 | John T. Treace Chief Executive Officer, Director, 10%… | TMCI Treace Medical Concepts, Inc. | Buy | 9,891 | $4.04 | $40.0K Buy | Form 4/A ↗ |
| Jun 10, 2026 | John T. Treace Chief Executive Officer, Director, 10%… | TMCI Treace Medical Concepts, Inc. | Buy | 14,715 | $4.02 | $59.2K Buy | Form 4/A ↗ |
| Jun 1, 2026 | John T. Treace Chief Executive Officer, Director, 10%… | TMCI Treace Medical Concepts, Inc. | Buy | 50,000 | $3.56 | $178.0K Buy | Form 4 ↗ |
| May 28, 2026 | John T. Treace Chief Executive Officer, Director, 10%… | TMCI Treace Medical Concepts, Inc. | Buy | 61,202 | $3.02 | $184.8K Buy | Form 4 ↗ |
| May 27, 2026 | John T. Treace Chief Executive Officer, Director, 10%… | TMCI Treace Medical Concepts, Inc. | Buy | 49,810 | $2.87 | $143.0K Buy | Form 4 ↗ |
| May 26, 2026 | John T. Treace Chief Executive Officer, Director, 10%… | TMCI Treace Medical Concepts, Inc. | Buy | 4,508 | $2.79 | $12.6K Buy | Form 4 ↗ |
| May 14, 2026 | John T. Treace Chief Executive Officer, Director, 10%… | TMCI Treace Medical Concepts, Inc. | Buy | 61,750 | $2.62 | $161.8K Buy | Form 4 ↗ |
| May 13, 2026 | John T. Treace Chief Executive Officer, Director, 10%… | TMCI Treace Medical Concepts, Inc. | Buy | 49,013 | $2.46 | $120.6K Buy | Form 4 ↗ |
| May 12, 2026 | John T. Treace Chief Executive Officer, Director, 10%… | TMCI Treace Medical Concepts, Inc. | Buy | 43,000 | $2.17 | $93.3K Buy | Form 4 ↗ |
| Mar 17, 2025 | Sean F. Scanlan Chief Innovation Officer | TMCI Treace Medical Concepts, Inc. | Sale | 50,000 | $7.97 | $398.5K Sale | Form 4 ↗ |
| Mar 4, 2025 | John T. Treace Chief Executive Officer, Director, 10%… | TMCI Treace Medical Concepts, Inc. | Buy | 60,000 | $8.73 | $523.8K Buy | Form 4 ↗ |
14 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:11 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances